在研课题：

1. 国家自然科学基金重大项目《慢阻肺早期疾病演进相关机制和靶标发现》，82090010，2021-2025

2. 国自然国际（地区）合作与交流项目《基于中英大规模队列研究的吸烟、慢性阻塞性肺疾病易感基因筛查及精准化戒烟治疗研究》，81720108001，2018-2022

3. 中国工程院咨询研究项目（重点）《中国与法国等发达国家结核病防治体系的对比研究》，2019-xz-30，2019-2021

代表性论文：

1. B. Cao, X. W. Li, Y. Mao, J.Wang, H. Z. Lu, Y. S. Chen, Z. A. Liang, L. Liang, S. J. Zhang, B. Zhang, L.Gu, L. H. Lu, D. Y. Wang and C. Wang (2009). "Clinical features of theinitial cases of 2009 pandemic influenza A (H1N1) virus infection in China."N Engl J Med 361(26): 2507-2517.

2. C. Wang, Z. Zhai, Y. Yang, Q.Wu, Z. Cheng, L. Liang, H. Dai, K. Huang, W. Lu, Z. Zhang, X. Cheng and Y. H.Shen (2010). "Efficacy and safety of low dose recombinant tissue-typeplasminogen activator for the treatment of acute pulmonary thromboembolism: arandomized, multicenter, controlled trial." Chest 137(2): 254-262.

3. C. Wang, B. Cao, Q. Q. Liu, Z.Q. Zou, Z. A. Liang, L. Gu, J. P. Dong, L. R. Liang, X. W. Li, K. Hu, X. S. He,Y. H. Sun, Y. An, T. Yang, Z. X. Cao, Y. M. Guo, X. M. Wen, Y. G. Wang, Y. L.Liu and L. D. Jiang (2011). "Oseltamivir compared with the Chinesetraditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza:a randomized trial." Ann Intern Med 155(4): 217-225.

4. Q. Zhan, B. Sun, L. Liang, X. Yan,L. Zhang, J. Yang, L. Wang, Z. Ma, L. Shi, L. Wei, G. Li, L. Yang, Z. Shi, Y.Chen, Q. Xu, W. Li, X. Zhu, Z. Wang, Y. Sun, J. Zhuo, Y. Liu, X. Li and C. Wang(2012). "Early use of noninvasive positive pressure ventilation for acutelung injury: a multicenter randomized controlled trial." Crit Care Med40(2): 455-460.

5. C. Wang and Q. Liu (2013)."A turning point for clinical research in China?" Lancet 382(9895):835-836.

6. R. Qiao, M. J. Rosen, R. Chen,S. Wu, D. Marciniuk and C. Wang (2014). "Establishing pulmonary andcritical care medicine as a subspecialty in China: joint statement of theChinese thoracic society and the American college of chest physicians."Chest 145(1): 27-29.

7. D. Xiao, C. X. Bai, Z. M. Chenand C. Wang (2015). "Implementation of the World Health OrganizationFramework Convention on Tobacco Control in China: An arduous and long-termtask." Cancer 121 Suppl 17: 3061-3068.

8. C. Wang, J. Xu, L. Yang, Y. Xu,X. Zhang, C. Bai, J. Kang, P. Ran, H. Shen, F. Wen, K. Huang, W. Yao, T. Sun,G. Shan, T. Yang, Y. Lin, S. Wu, J. Zhu, R. Wang, Z. Shi, J. Zhao, X. Ye, Y.Song, Q. Wang, Y. Zhou, L. Ding, T. Yang, Y. Chen, Y. Guo, F. Xiao, Y. Lu, X.Peng, B. Zhang, D. Xiao, C. S. Chen, Z. Wang, H. Zhang, X. Bu, X. Zhang, L. An,S. Zhang, Z. Cao, Q. Zhan, Y. Yang, B. Cao, H. Dai, L. Liang and J. He (2018)."Prevalence and risk factors of chronic obstructive pulmonary disease inChina (the China Pulmonary Health [CPH] study): a national cross-sectionalstudy." Lancet 391(10131): 1706-1717.

9. Wang C, Zhai X, Zhang X, Li L,Wang J, Liu DP; Chinese Academy of Medical Sciences. (2019) Gene-edited babies:Chinese Academy of Medical Sciences' response and action. Lancet. 2019 Jan5;393(10166):25-26.

10. Huang K, Yang T, Xu J, Yang L,Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, Wen F, Chen Y, Sun T, Shan G,Lin Y, Xu G, Wu S, Wang C, Wang R, Shi Z, Xu Y, Ye X, Song Y, Wang Q, Zhou Y,Li W, Ding L, Wan C, Yao W, Guo Y, Xiao F, Lu Y, Peng X, Zhang B, Xiao D, WangZ, Chen Z, Bu X, Zhang H, Zhang X, An L, Zhang S, Zhu J, Cao Z, Zhan Q, Yang Y,Liang L, Tong X, Dai H, Cao B, Wu T, Chung KF, He J, Wang C. (2019) Prevalence,risk factors, and management of asthma in China: a national cross-sectionalstudy. Lancet. 2019 Aug 3;394(10196):407-418.

11. Wang C, Chen S, Zhu J, Li W.(2019) China's new 4 + 4 medical education programme. Lancet. 2019 Sep28;394(10204):1121-1123.

12. Wang, C, Horby, P. W., Hayden,F. G., & Gao, G. F. (2020). A novel coronavirus outbreak of global healthconcern. The Lancet.

13. Cao B, Wang Y, Wen D, Liu W, Wang J, FanG, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, XieX, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y,Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, ZhouX, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, ZouJ, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, HuangC, Jaki T, Hayden FG, Horby PW, Zhang D, WangC. (2020) A Trial of Lopinavir-Ritonavir in Adults Hospitalized with SevereCovid-19. N Engl J Med. 2020 May 7;382(19):1787-1799.

14. Wang Y, Zhang D, Du G, Du R, Zhao J, JinY, Fu S,Gao L, Cheng Z, Lu Q, Hu Y, Luog, Wang K, Lu Y, Li H, Wang S, Ruan S,Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, WangA, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, QinH, Jiang Y, Jaki T, Hayden F G, Horby P W, Cao B, Wang C. (2020) Remdesivir in Adults with Severe COVID-19: A Randomised,Double-Blind, Placebo-Controlled, Multicentre Trial. Lancet. online 29 April2020

15. Chen S, Zhang Z, Yang J, Wang J, Zhai X,Bärnighausen T, Wang C. (2020) FangcangShelter Hospitals: A Novel Concept for Responding to Public Health Emergencies.Lancet. 2020 Apr 18;395(10232):1305-1314.

16.He Z, Ren L, Yang J, Guo L, Feng L, Ma C, Wang X, Leng Z, Tong X, Zhou W, Wang G, Zhang T, Guo Y, Wu C, Wang Q, Liu M, Wang C, Jia M, Hu X, Wang Y, Zhang X, Hu R, Zhong J, Yang J, Dai J, Chen L, Zhou X, Wang J, Yang W, Wang C.(2020)  Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet. 2021 Mar 20;397(10279):1075-1084